- UCLA Jonsson Comprehensive Cancer Center announces new leadership appointments
We are pleased to announce the appointment of Kathrin Plath, PhD, Hanna Mikkola, MD, PhD and William Lowry, PhD to three leadership positions at the Cancer Center, beginning April 1.
March 29, 2023 11:00 AM
detail - New details on how immune cells ‘see’ and respond to mutations in cancer cells may lead to more targeted and effective immunotherapy
For the first time, a research team has identified and analyzed the steps by which immune cells “see” and respond to cancer cells, providing insights into reasons some treatments may be effective for certain patients but not others.
March 08, 2023 11:00 AM
detail - Breast cancer risk models may incorrectly classify many women
Breast cancer risk estimates for individual women vary substantially depending on which risk assessment model is used, and women are likely receiving vastly different recommendations depending on the model used and the cutoff applied to define "high risk," according to a new UCLA study.
February 17, 2023 9:00 AM
detail - Coping with a cancer diagnosis
Hearing a doctor say, “You have cancer” is a pivotal moment in anyone’s life. In this story, Dr. Elizabeth Cleary offers guidance for how to cope with a cancer diagnosis
February 03, 2023 6:30 AM
detail - Dr. Elizabeth Cleary brings heart, personal experience to healing
From her earliest days at Harvard, Elizabeth Cleary, PhD, was interested in mental health.
February 01, 2023 6:30 AM
detail - UCLA researchers identify possible approach to prevent cancer from evolving to resist treatment
A new clinical and preclinical study from UCLA Jonsson Comprehensive Cancer Center identifies the DNA roots of resistance to targeted cancer therapy, providing a possible strategy to address a vexing issue in cancer therapeutics. Results are published online ahead of print in Cancer Discovery, a journal of the American Association for Cancer Research.
January 26, 2023 8:30 AM
detail - Tiny implantable device designed by UCLA scientists helps kill cancer
Many solid tumors resist treatment in part by turning human biology against itself. Tumors surround themselves with extra white blood cells known as regulatory T cells, which call off the body’s natural defenses against the disease.
January 25, 2023 6:00 AM
detail - A 4-drug chemotherapy regimen improves survival in stage 4 pancreas cancer
A four-drug chemotherapy regimen provided longer overall survival than a two-drug combination in a Phase 3 clinical trial for metastatic pancreatic ductal adenocarcinoma. The study is believed to be the first metastatic pancreatic cancer study in nearly a decade to have a positive endpoint for overall survival.
January 20, 2023 7:30 AM
detail - MRI-guided radiotherapy produces fewer side effects and better quality of life for patients with localized prostate cancer
For men who undergo radiotherapy for localized prostate cancer, the precise targeting capabilities of MRI guidance resulted in fewer toxicities and better quality of life, as judged by patients and the doctors treating them.
January 12, 2023 8:00 AM
detail